Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-019975-30Phase 4Completed
Phase 4, randomised trial of dorzolamide + timolol in Glaucoma (2 arms), sponsored by University Medical Center Mainz. Primary endpoint: Mean intraocular pressure reduction at 3 months post-trabeculectomy. Started Jun 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-019975-30.